✦ LIBER ✦

Predictive value of VEGF gene polymorphisms for metastatic colorectal cancer patients receiving first-line treatment including fluorouracil, irinotecan, and bevacizumab

✍ Scribed by Vincenzo Formica; Raffaele Palmirotta; Girolamo Del Monte; Annalisa Savonarola; Giorgia Ludovici; Maria Laura De Marchis; Italia Grenga; Michele Schirru; Fiorella Guadagni; Mario Roselli

Book ID: 106060164
Publisher: Springer
Year: 2010
Tongue: English
Weight: 177 KB
Volume: 26
Category: Article
ISSN: 0179-1958
DOI: 10.1007/s00384-010-1108-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6115 VEGF gene polymorphisms in the pred

6115 VEGF gene polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab (BV) in metastatic colorectal cancer (mCRC) patients (pts)

✍ Loupakis, F.; Ruzzo, A.; Salvatore, L.; Canestrari, E.; Cremolini, C.; Santini, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

The predictive value of single nucleotid

The predictive value of single nucleotide polymorphisms in the VEGF system to the efficacy of first-line treatment with bevacizumab plus chemotherapy in patients with metastatic colorectal cancer

✍ Hansen, Torben Frøstrup; Christensen, René dePont; Andersen, Rikke Fredslund; Sp 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 135 KB

Safety and efficacy of second-line treat

Safety and efficacy of second-line treatment with folinic acid, 5-fluorouracil and irinotecan (FOLFIRI) in combination of panitumumab and bevacizumab for patients with metastatic colorectal cancer

✍ Xie, Song; Han, Guoping; Fan, Zhikun; He, Lifeng; Xu, Wenbing; Qin, Zhen 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 253 KB

PCN33 ECONOMIC EVALUATION OF FIRST-LINE

PCN33 ECONOMIC EVALUATION OF FIRST-LINE TREATMENT FOR METASTATIC COLORECTAL CANCER (MCRC) BASED ON IRINOTECAN (FOLFIRI) + BEVACIZUMAB OR CETUXIMAB, ADJUSTED BY KRAS GENE (WILD-TYPE (WT) OR MUTANT (MT))

✍ L Torrecillas; J Vargas 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB